Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 26-50 of 118 citing articles:

Elucidation of Structural Elements for Selectivity across Monoamine Transporters: Novel 2-[(Diphenylmethyl)sulfinyl]acetamide (Modafinil) Analogues
Oluyomi M. Okunola-Bakare, Jianjing Cao, Theresa Kopajtic, et al.
Journal of Medicinal Chemistry (2014) Vol. 57, Iss. 3, pp. 1000-1013
Open Access | Times Cited: 51
Modafinil attenuates reinstatement of cocaine seeking: role for cystine-glutamate exchange and metabotropic glutamate receptors
Stephen V. Mahler, Megan E. Hensley-Simon, Pouya Tahsili‐Fahadan, et al.
Addiction Biology (2012) Vol. 19, Iss. 1, pp. 49-60
Open Access | Times Cited: 47
Sites of action of sleep and wake drugs: insights from model organisms
Jason Rihel, Alexander F. Schier
Current Opinion in Neurobiology (2013) Vol. 23, Iss. 5, pp. 831-840
Open Access | Times Cited: 45
Preference for Distinct Functional Conformations of the Dopamine Transporter Alters the Relationship between Subjective Effects of Cocaine and Stimulation of Mesolimbic Dopamine
Stephen J. Kohut, Takato Hiranita, Soo‐Kyung Hong, et al.
Biological Psychiatry (2014) Vol. 76, Iss. 10, pp. 802-809
Open Access | Times Cited: 44
Treatment with modafinil and escitalopram, alone and in combination, on cocaine-induced effects: A randomized, double blind, placebo-controlled human laboratory study
Christopher D. Verrico, Colin N. Haile, James J. Mahoney, et al.
Drug and Alcohol Dependence (2014) Vol. 141, pp. 72-78
Open Access | Times Cited: 42
Use of Stimulants in Bipolar Disorder
Giulio Perugi, Giulia Vannucchi, Fulvio Bedani, et al.
Current Psychiatry Reports (2017) Vol. 19, Iss. 1
Closed Access | Times Cited: 42
Conformational state interactions provide clues to the pharmacochaperone potential of serotonin transporter partial substrates
Shreyas Bhat, Peter S. Hasenhuetl, Ameya Kasture, et al.
Journal of Biological Chemistry (2017) Vol. 292, Iss. 40, pp. 16773-16786
Open Access | Times Cited: 41
The Novel Atypical Dopamine Uptake Inhibitor (S)-CE-123 Partially Reverses the Effort-Related Effects of the Dopamine Depleting Agent Tetrabenazine and Increases Progressive Ratio Responding
Renee A. Rotolo, Vladimir Dragačević, Predrag Kalaba, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 41
Parental ADHD in pregnancy and the postpartum period – A systematic review
Sarah Kittel‐Schneider, Boris B. Quednow, Anna Linda Leutritz, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 124, pp. 63-77
Open Access | Times Cited: 29
Dopamine transporter oligomerization: impact of combining protomers with differential cocaine analog binding affinities
Juan Zhen, Tamara Antonio, Shu‐Yuan Cheng, et al.
Journal of Neurochemistry (2015) Vol. 133, Iss. 2, pp. 167-173
Open Access | Times Cited: 36
Molecular Mechanisms of Amphetamines
Maarten E. A. Reith, Margaret E. Gnegy
Handbook of experimental pharmacology (2019), pp. 265-297
Closed Access | Times Cited: 35
The unique psychostimulant profile of (±)‐modafinil: investigation of behavioral and neurochemical effects in mice
Maddalena Mereu, Lauren E. Chun, Thomas E. Prisinzano, et al.
European Journal of Neuroscience (2016) Vol. 45, Iss. 1, pp. 167-174
Open Access | Times Cited: 33
Small molecule induced oligomerization, clustering and clathrin-independent endocytosis of the dopamine transporter
Tatiana Sorkina, Shiqi Ma, Mads Larsen, et al.
eLife (2018) Vol. 7
Open Access | Times Cited: 33
How to rescue misfolded SERT, DAT and NET: targeting conformational intermediates with atypical inhibitors and partial releasers
Shreyas Bhat, Amy Hauck Newman, Michael Freissmuth
Biochemical Society Transactions (2019) Vol. 47, Iss. 3, pp. 861-874
Open Access | Times Cited: 30
Behavioral and dopamine transporter binding properties of the modafinil analog (S, S)-CE-158: reversal of the motivational effects of tetrabenazine and enhancement of progressive ratio responding
Renee A. Rotolo, Predrag Kalaba, Vladimir Dragačević, et al.
Psychopharmacology (2020) Vol. 237, Iss. 11, pp. 3459-3470
Open Access | Times Cited: 29
Potential therapeutics for effort-related motivational dysfunction: assessing novel atypical dopamine transport inhibitors
Alev Ecevitoglu, Nicolette Meka, Renee A. Rotolo, et al.
Neuropsychopharmacology (2024) Vol. 49, Iss. 8, pp. 1309-1317
Closed Access | Times Cited: 3
Zinc for treating of children and adolescents with attention-deficit hyperactivity disorder: a systematic review of randomized controlled clinical trials
Ahmad Ghanizadeh, Michael Berk
European Journal of Clinical Nutrition (2012) Vol. 67, Iss. 1, pp. 122-124
Open Access | Times Cited: 33
The Novel Modafinil Analog, JJC8-016, as a Potential Cocaine Abuse Pharmacotherapeutic
Hai‐Ying Zhang, Guo-Hua Bi, Hong-Ju Yang, et al.
Neuropsychopharmacology (2017) Vol. 42, Iss. 9, pp. 1871-1883
Open Access | Times Cited: 31
Effects of (R)-Modafinil and Modafinil Analogues on Dopamine Dynamics Assessed by Voltammetry and Microdialysis in the Mouse Nucleus Accumbens Shell
Jacqueline D. Keighron, Juliana C. Quarterman, Jianjing Cao, et al.
ACS Chemical Neuroscience (2019) Vol. 10, Iss. 4, pp. 2012-2021
Open Access | Times Cited: 27
Prodopaminergic Drugs for Treating the Negative Symptoms of Schizophrenia
Michel Sabé, Matthias Kirschner, Stefan Kaiser
Journal of Clinical Psychopharmacology (2019) Vol. 39, Iss. 6, pp. 658-664
Closed Access | Times Cited: 27
The off-prescription use of modafinil: An online survey of perceived risks and benefits
Rachel D. Teodorini, N. Rycroft, James H. Smith‐Spark
PLoS ONE (2020) Vol. 15, Iss. 2, pp. e0227818-e0227818
Open Access | Times Cited: 24
Interactions of calmodulin kinase II with the dopamine transporter facilitate cocaine-induced enhancement of evoked dopamine release
Jacqueline D. Keighron, Jordi Bonaventura, Li Yang, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Heterocyclic Analogues of Modafinil as Novel, Atypical Dopamine Transporter Inhibitors
Predrag Kalaba, Nilima Y. Aher, Marija Ilić, et al.
Journal of Medicinal Chemistry (2017) Vol. 60, Iss. 22, pp. 9330-9348
Closed Access | Times Cited: 28
Atypical dopamine transporter inhibitors attenuate compulsive-like methamphetamine self-administration in rats
Brendan J. Tunstall, Chelsea P. Ho, Jianjing Cao, et al.
Neuropharmacology (2017) Vol. 131, pp. 96-103
Open Access | Times Cited: 28
Model systems for analysis of dopamine transporter function and regulation
Moriah J. Hovde, Garret H. Larson, Roxanne A. Vaughan, et al.
Neurochemistry International (2018) Vol. 123, pp. 13-21
Open Access | Times Cited: 27

Scroll to top